Laboratory Corporation of America Holdings
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer
 Common Stock 212 $240 $50,880
Option
KIRCHGRABER PAUL R officer: CEO, Covance Drug Deve..
 Non-qualified Stock Options 4,300 $182.51 $784,793
Option
KIRCHGRABER PAUL R officer: CEO, Covance Drug Deve..
 Common Stock 4,300 $182.51 $784,793
Sale
KIRCHGRABER PAUL R officer: CEO, Covance Drug Deve..
 Common Stock 4,300 $216.91 $932,709
Option
SCHROEDER MARK S officer: EVP, Pres Diagnostics ..
 Common Stock 1,500 $130.6 $195,900
Sale
SCHROEDER MARK S officer: EVP, Pres Diagnostics ..
 Common Stock 1,500 $216.77 $325,155
Option
SCHROEDER MARK S officer: EVP, Pres Diagnostics ..
 Non-qualified Stock Options 1,500 $130.6 $195,900
Sale
SCHROEDER MARK S officer: EVP, President-Diagnos..
 Common Stock 3,897 $225.81 $879,982
Option
SUMMY AMY B. officer: EVP, Chief Marketing O..
 Restricted Stock Unit 1,340 N/A N/A
Option
SUMMY AMY B. officer: EVP, Chief Marketing O..
 Common Stock 1,340 N/A N/A
Option
KIRCHGRABER PAUL R officer: CEO, Covance Drug Deve..
 Non-qualified Stock Options 3,000 $182.51 $547,530
Sale
KIRCHGRABER PAUL R officer: CEO, Covance Drug Deve..
 Common Stock 8,000 $250.58 $2,004,672
Option
KIRCHGRABER PAUL R officer: CEO, Covance Drug Deve..
 Common Stock 3,000 $182.51 $547,530
Sale
SCHROEDER MARK S officer: EVP, President-Diagnos..
 Common Stock 309 $247.63 $76,518
Option
KIRCHGRABER PAUL R officer: CEO, Covance Drug Deve..
 Restricted Stock Unit 483 N/A N/A
Option
KIRCHGRABER PAUL R officer: CEO, Covance Drug Deve..
 Common Stock 483 N/A N/A
Option
CAVENEY BRIAN J officer: EVP, President of Diag..
 Restricted Stock Unit 423 N/A N/A
Option
CAVENEY BRIAN J officer: EVP, President of Diag..
 Common Stock 423 N/A N/A
Option
SCHECHTER ADAM H director, officer: President & ..
 Restricted Stock Unit 2,656 N/A N/A
Option
SCHECHTER ADAM H director, officer: President & ..
 Common Stock 2,656 N/A N/A
Option
EISENBERG GLENN A officer: Chief Financial Office..
 Restricted Stock Unit 723 N/A N/A
Option
EISENBERG GLENN A officer: Chief Financial Office..
 Common Stock 723 N/A N/A
Option
SCHROEDER MARK S officer: EVP, President-Diagnos..
 Restricted Stock Unit 423 N/A N/A
Option
SCHROEDER MARK S officer: EVP, President-Diagnos..
 Common Stock 423 N/A N/A
Option
SELTZ JUDITH C officer: EVP, CHRO
 Restricted Stock Unit 236 N/A N/A
Option
SELTZ JUDITH C officer: EVP, CHRO
 Common Stock 236 N/A N/A
Option
WILKINSON PETER J officer: SVP, Chief Accounting ..
 Restricted Stock Unit 110 N/A N/A
Option
WILKINSON PETER J officer: SVP, Chief Accounting ..
 Common Stock 110 N/A N/A
Option
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer
 Restricted Stock Unit 290 N/A N/A
Option
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer
 Common Stock 290 N/A N/A
Option
SUMMY AMY B. officer: EVP, Chief Marketing O..
 Restricted Stock Unit 180 N/A N/A
Option
SUMMY AMY B. officer: EVP, Chief Marketing O..
 Common Stock 180 N/A N/A
Sale
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer
 Common Stock 219 $243.01 $53,219
Sale
SCHROEDER MARK S officer: EVP, President-Diagnos..
 Common Stock 409 $243.01 $99,391
Option
SCHECHTER ADAM H director, officer: President & ..
 Restricted Stock Unit 3,507 N/A N/A
Option
SCHECHTER ADAM H director, officer: President & ..
 Common Stock 3,507 N/A N/A
Option
CAVENEY BRIAN J officer: EVP, President of Diag..
 Restricted Stock Unit 560 N/A N/A
Option
CAVENEY BRIAN J officer: EVP, President of Diag..
 Common Stock 560 N/A N/A
Option
EISENBERG GLENN A officer: Chief Financial Office..
 Restricted Stock Unit 970 N/A N/A
Option
EISENBERG GLENN A officer: Chief Financial Office..
 Common Stock 970 N/A N/A
Option
BERBERIAN LANCE officer: EVP, CIO & CTO
 Restricted Stock Unit 374 N/A N/A
Option
BERBERIAN LANCE officer: EVP, CIO & CTO
 Common Stock 374 N/A N/A
Option
KIRCHGRABER PAUL R officer: CEO, Covance Drug Deve..
 Restricted Stock Unit 560 N/A N/A
Option
KIRCHGRABER PAUL R officer: CEO, Covance Drug Deve..
 Common Stock 560 N/A N/A
Option
SCHROEDER MARK S officer: EVP, President-Diagnos..
 Restricted Stock Unit 560 N/A N/A
Option
SCHROEDER MARK S officer: EVP, President-Diagnos..
 Common Stock 560 N/A N/A
Option
WILKINSON PETER J officer: SVP, Chief Accounting ..
 Restricted Stock Unit 150 N/A N/A
Option
WILKINSON PETER J officer: SVP, Chief Accounting ..
 Common Stock 150 N/A N/A
Option
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer
 Restricted Stock Unit 300 N/A N/A
Option
VAN DER VAART SANDRA D officer: EVP, Chief Legal Officer
 Common Stock 300 N/A N/A

Showing 150 to 200 of 1677 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: